Hacker News Reader

I may have been using rhetoric; but I would be surprised if the direct cost ( lab time, process control, packaging, etc. ) were more than $40/dose.

And consider that most of the research on which Humira, Embrel etc. came from was sponsored by the US Taxpayer.

View on HN

I don’t have specific knowledge on Humira or its biosimilars, but $40 is more reasonable.

To be specific, Humira was developed from research by BASF Bioresearch (bought by Abbott) and a research consortium in the UK, so credit to the UK taxpayers is warranted; I’m not sure about the US side.

Nevertheless, government sponsored research largely does not cover the development of the drug, and those costs are somewhere in the hundreds of millions USD range on up.

Reply on news.ycombinator.com